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1. INTRODUCTION 
The Diabetes Prevention Impact Toolkit was developed by RTI International for the Centers 
for Disease Control and Prevention (CDC). The purpose of the Impact Toolkit is to project 
the health and economic effects of the National Diabetes Prevention Program (National DPP) 
or similar programs on state, employer, and insurer populations at risk for diabetes.  
The Impact Toolkit includes three modules, as seen on the homepage (Figure 1): 
• The State module provides results at the state level.  
• The Employer module allows users to generate customized results for their employee 
population.  
• The Insurer module allows users to generate customized results for their insured 
population.  
Figure 1. Diabetes Prevention Impact Toolkit Homepage 
 
 
The modules are very similar, with the main difference in the Population Characteristics 
section of the Input Dashboard. Specifically, in the Employer and Insurer modules, users 
can choose from a set of predefined populations or enter a customized set of population 
characteristics, whereas in the State module, users are only offered state populations. 
Sections 2.1 through 2.3 describe the Population Characteristics inputs for each module 
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separately. All other sections of this user manual apply to all three modules, except for 
Section 2.5.7 Productivity Costs, which only applies to the Employer module. 
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2. INPUT DASHBOARD 
For each module (State, Employer, and Insurer), the Population Characteristics section of 
the Input Dashboard has different features and functions. These Population Characteristics 
are described in the following sections. Section 2.1 covers the technical details of population 
characteristics for the State module, Section 2.2 covers the Employer module, and Section 
2.3 covers the Insurer module. Sections 2.4 and 2.5 cover the technical details associated 
with additional sections of the Input Dashboard that are the same in each module (e.g., 
screening assumptions, cost assumptions). 
When you first open the Input Dashboard for one of the modules (Figure 2 shows the Input 
Dashboard for the State module), you will see a limited set of inputs. To obtain baseline 
results quickly, make selections from this limited set of inputs and then click “GET 
RESULTS.” If you do not change any of these inputs, results will be generated based on 
default values for the population. In the State module, you must select a state before 
clicking “GET RESULTS.” 
To view the full set of inputs and selections, click “CUSTOMIZE FURTHER.” All inputs are set 
to a default value that reflects the average costs, effects, screening history, and 
participation rates of a U.S.-based National DPP or similar program. However, your state or 
organization’s inputs and selections may differ from the average. To learn more about how 
to customize inputs, continue reading Section 2 (Input Dashboard). To learn more about 
interpreting the Impact Toolkit results, see Section 3 (Output Dashboard). For a checklist of 
all data items and selection decisions that you can customize, refer to the Data Input 
Checklists provided for each module on the Impact Toolkit’s HELP page. To learn more 
about an input field in real time, hover over the green circles with an “i” in the center. These 
“tooltips” display a few key points related to the adjacent text or input field. 
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Figure 2. State Input Dashboard 
 
 
2.1 State Module Population Characteristics 
When a state is selected from the dropdown list (or the U.S. map) shown in Figure 2, the 
Impact Toolkit references a table of state-level population data. The number of adults in 
your state (or national) selection will automatically populate next to the heading “Number of 
Adults.” Another table stored in the State module contains the state-specific predicted 
prevalence for each of the risk groups eligible to participate in the National DPP or similar 
programs. The default risk group is set to “Persons with prediabetes,” but you can also 
select a larger group (“Persons with prediabetes and other persons at risk for type 2 
diabetes”) or a smaller group (“Persons with high-risk prediabetes”). These risk groups only 
include persons who are eligible for the National DPP (body mass index [BMI] ≥ 24 kg/m2). 
See Section 2.4 for more information on how these groups are defined. 
National estimates offered in the State module (“UNITED STATES” selection in the dropdown 
menu) do not use a prediction equation to predict the prevalence of “Persons with 
prediabetes” because their prediabetes status is obtained directly from the results of the 
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National Health and Nutrition Examination Survey (NHANES) laboratory data (i.e., A1C or 
fasting plasma glucose [FPG] test results). Thus, we used the NHANES data (2011–2014)  
for the U.S. population selection in the State module, whereas state-level data were based 
on (1) the prediabetes prediction equation estimated in NHANES (2011–2014) and (2) the 
state-level characteristics observed in the Behavioral Risk Factor Surveillance System 
(BRFSS) (2014). Depending on your screening and participation assumptions (see Sections 
2.5.1 and 2.5.2), only a fraction of the eligible state residents will end up participating and 
reducing their risk of progression to diabetes. 
2.2 Employer Module Population Characteristics 
Before selecting a radio button to designate your population’s characteristics, you will first 
enter your population size (i.e. “Number of Employees” in the Employer module). This 
number should include all employees, not just those eligible or participating in a prevention 
program. The default number of employees is set to 1,000 as shown in Figure 3. 
Figure 3. Employer Input Dashboard 
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Once you have entered the total number of employees at a firm, you will then select a radio 
button to determine the population characteristics of your employee population. There are 
several predefined sets of population characteristics as well as an option to enter your own 
employee population characteristics (age, race/ethnicity, sex, body weight). The proportion 
of the population that is eligible for the National DPP will be calculated using the set of 
population characteristics defined here and a prediction equation estimated in NHANES 
(2011–2014). 
2.2.1 Assume National Average for Population Characteristics 
Choose this option if you would like to use national averages for population characteristics 
and prediabetes rates. National characteristics are survey-weighted estimates from the 
sample of U.S. persons in NHANES (2011–2014). 
2.2.2 Assume State Average for Population Characteristics 
Choose this option if you would like to use a particular state’s averages for population 
characteristics and prediabetes rates. State characteristics are survey-weighted estimates 
from the sample of each state’s residents in the BRFSS (2014).  
2.2.3 Assume Industry Average for Population Characteristics 
Choose this option if you would like to use a particular industry’s averages for population 
characteristics. Industry population characteristics are based on the sample of employed 
persons in NHANES (2011–2014) and the relative rates of obesity across industry groups 
reported in Luckhaupt et al. (2014). Industries are defined in NHANES using the U.S. 
Census Bureau’s 2002 Occupation and Industry coding system (U.S. Census, 2016). If you 
do not see a choice that matches your industry, select state or national averages, or enter 
your own employee population characteristics. 
2.2.4 Assume Occupation Average for Population Characteristics 
Choose this option if you would like to use a particular occupation’s averages for population 
characteristics. Occupation population characteristics are based on the sample of employed 
persons in NHANES (2011–2014) and the relative rates of obesity across occupation groups 
reported in Luckhaupt et al. (2014). Occupations are defined in NHANES using the U.S. 
Census Bureau’s 2002 Occupation and Industry coding system (U.S. Census, 2016). If you 
do not see a choice that matches your occupation, select state or national averages, or 
enter your own employee population characteristics. 
2.2.5 Entering Employee Population Characteristics 
For customized results based on your organization’s unique population characteristics, select 
the “Enter employee characteristics” option. When this option is selected, you will see that 
the fields for each characteristic have already been filled with default values that reflect 
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national averages for the employed population in the United States. You can change these 
values to reflect your own employee population characteristics. Each of the population 
characteristics breakdowns (age, race/ethnicity, sex, and body weight) are for the overall 
population. For example, the various age groups in the age breakdown box are for all male 
and female employees; different age breakdowns for males and females cannot be entered 
in the Impact Toolkit. To return to the default values at any point, click the “RESTORE 
DEFAULTS” link in the upper right-hand corner (see Figure 3). This button will clear all of 
the data that you have entered and restore the default data. The values entered in the 
employee characteristics fields are used to predict the percentage of employees in each risk 
group (see Section 2.4 for more information on risk groups). 
Age Breakdown 
Enter the percentage of your employee population that is in each age group. The sum of 
these categories should equal 100%. 
Race/Ethnicity Breakdown 
Enter the percentage of your employee population that is in each race/ethnicity group. The 
sum of these categories should equal 100%. The “Other Race/Ethnicity” group includes 
other non-Hispanic races and non-Hispanic multiracial persons based on NHANES 2011–
2014 race/ethnicity definitions. 
Sex Breakdown 
Enter the percentage of your employee population that is in each sex group. The sum of 
these categories should equal 100%. 
Body Weight Breakdown 
Enter the percentage of your employee population that is in each body weight group. For 
the purposes of this tool, include the percentage of underweight employees in the normal 
weight category. To match National DPP eligibility requirements, the BMI range for 
overweight is expanded beyond its typical clinical definition (≥25.0 kg/m2). The BMI ranges 
for each category are as follows: 
• <24.0 kg/m2: Normal weight and underweight 
• 24.0 kg/m2–29.9 kg/m2: Overweight1 
• ≥30.0 kg/m2: Obese 
                                          
1 We defined overweight with a lower BMI threshold of 24.0 kg/m2 to match CDC criteria for 
participation in the National DPP (CDC, 2015b). State and national estimates use a lower BMI 
threshold (22.0 kg/m2) for Asian participants in the National DPP (CDC, 2015b); however, the “Enter 
employee characteristics” does not account for different BMI thresholds by race/ethnicity. This may 
have a small downward effect on the number of projected participants when a substantial share of the 
employee population is Asian. 
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Only overweight and obese employees are eligible for participation. The sum of the three 
body weight categories should be 100%. 
2.3 Insurer Module Population Characteristics 
Before selecting a radio button to designate your population’s characteristics, you will first 
enter your population size (i.e., “Number of Adults Insured” in the Insurer module). This 
number should include all privately insured adults, not just those participating in a 
prevention program. The default number of privately insured adults is set to 1,000 as shown 
in Figure 4. 
Figure 4. Insurer Input Dashboard 
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Once you have entered the total number of privately insured adults in your population, you 
then will select a radio button to determine the population characteristics of your 
population. There are several predefined sets of population characteristics as well as an 
option to enter your own privately insured adult population characteristics (age, 
race/ethnicity, sex, body weight). The proportion of the population that is eligible for the 
National DPP will be calculated using the set of population characteristics defined here and a 
prediction equation estimated in NHANES (2011–2014). 
2.3.1 Assume National Average for Population Characteristics 
Choose this option if you would like to use national averages for population characteristics 
and prediabetes rates. National characteristics are survey-weighted estimates from the 
sample of U.S. persons in NHANES (2011–2014). 
2.3.2 Assume State Average for Population Characteristics 
Choose this option if you would like to use a particular state’s averages for population 
characteristics and prediabetes rates. State characteristics are survey-weighted estimates 
from the sample of each state’s residents in BRFSS (2014). 
2.3.3 Assume Industry Average for Population Characteristics 
Choose this option if you would like to use a particular industry’s averages for population 
characteristics. Industry population characteristics are based on the sample of employed 
persons in NHANES (2011–2014) and the relative rates of obesity across industry groups 
reported in Luckhaupt et al. (2014). Industries are defined using the U.S. Census Bureau’s 
2002 Occupation and Industry coding system (U.S. Census, 2016). If you do not see a 
choice that matches your industry, select state or national averages, or enter your own 
insured population characteristics. 
2.3.4 Assume Occupation Average for Population Characteristics 
Choose this option if you would like to use a particular occupation’s averages for population 
characteristics. Occupation characteristics are based on the sample of employed persons in 
NHANES (2011–2014) and the relative rates of obesity across occupation groups reported in 
Luckhaupt et al. (2014). Occupations are defined in NHANES using the U.S. Census 
Bureau’s 2002 Occupation and Industry coding system (U.S. Census, 2016). If you do not 
see a choice that matches your occupation, select state or national averages, or enter your 
own insured population characteristics. 
2.3.5 Entering Insured Population Characteristics 
For customized results based on your unique insured adult population’s characteristics, 
select the “Enter insured adult population characteristics” option. When this option is 
selected, you will see that the fields for each characteristic have already been filled with 
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default values that reflect national averages for the privately insured adult population in the 
United States. You can change these values to reflect your own privately insured adult 
population characteristics. To return to the default values at any point, click the “RESTORE 
DEFAULTS” link in the upper right-hand corner (Figure 4). This button will clear all of the 
data that you have entered and restore the default data. The Data Input Checklist (see 
Section 3) can be used as a tool to help collect the required input data. The checklist is also 
available through a PDF link on the Input Dashboard page. The values entered in the 
insured adult population characteristics fields are used to predict the percentage of insured 
adults in each risk group (see Section 2.4 for more information on risk groups). 
Age Breakdown 
Enter the percentage of your insured adult population that is in each age group. The sum of 
these categories should equal 100%. 
Race/Ethnicity Breakdown 
Enter the percentage of your insured adult population that is in each race/ethnicity group. 
The sum of these categories should equal 100%. The “Other Race/Ethnicity” group includes 
other non-Hispanic races and non-Hispanic multiracial persons based on NHANES 2011–
2014 race/ethnicity definitions. 
Sex Breakdown 
Enter the percentage of your insured adult population that is in each sex group. The sum of 
these categories should equal 100%. 
Body Weight Breakdown 
Enter the percentage of your insured adult population that is in each body weight group. For 
the purposes of this tool, include the percentage of underweight insured adults in the 
normal weight category. To match National DPP eligibility requirements, the BMI range for 
overweight is expanded beyond its typical clinical definition. The BMI ranges for each 
category are as follows: 
• <24.0 kg/m2: Normal weight 
• 24.0 kg/m2–29.9 kg/m2: Overweight2 
• ≥30.0 kg/m2: Obese 
                                          
2 We defined overweight with a lower BMI threshold of 24.0 kg/m2 to match CDC criteria for 
participation in the National DPP (CDC, 2015b). State and national estimates use a lower BMI 
threshold (22.0 kg/m2) for Asian participants in the National DPP (CDC, 2015b); however, the “Enter 
employee characteristics” does not account for different BMI thresholds by race/ethnicity. This may 
have a small downward effect on the number of projected participants when a substantial share of the 
employee population is Asian. 
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Only overweight and obese employees are eligible for participation. The sum of the three 
body weight categories should be 100%. 
2.4 Risk Group to Participate in Program 
After defining your population characteristics, based on one of the predefined populations or 
your own data, select a risk group to participate in the program. Using the radio buttons 
under the “Risk Group to Participate in Program” heading, you can select from the three risk 
groups eligible for the National DPP. The annual probability of developing diabetes is 
different for each risk group. The default annual probability for each risk group is 
prepopulated in the input box. You can change this number if you would like to assume a 
higher or lower probability of diabetes. We recommend using the default annual 
probabilities of diabetes unless you have (1) read this section of the technical report and 
(2) generated inputs from your own data sources or identified updated data available in the 
scientific literature. 
2.4.1 Persons with Prediabetes 
This group includes persons predicted to have prediabetes (and BMI≥24 kg/m2). “Persons 
with prediabetes” have a blood sugar level higher than normal, but not high enough for a 
diagnosis of diabetes (FPG 100–125 mg/dl or A1C 5.7%–6.4%). The default annual 
probability of diabetes for persons with prediabetes is 3.8%.  
This risk category is the default value for the Impact Toolkit because the American Diabetes 
Association (ADA) and other organizations recommend that persons with prediabetes be 
referred to an intensive diet and physical activity behavioral counseling program (ADA, 
2016). The National DPP is an example of such a program.   
2.4.2 Persons with Prediabetes and Other Persons at Risk for Type 2 
Diabetes  
This is the largest group, as it includes all “Persons with prediabetes” and “other persons at 
risk for type 2 diabetes” who have BMI≥24 kg/m2. This group is generally about 1.5 times 
larger than the risk group of persons with prediabetes. “Other persons at risk for type 2 
diabetes” were defined using criteria from the CDC Prediabetes Screening Test (CDC, 2015). 
A score of 9 or higher on the Prediabetes Screening Test determines whether a person is at 
risk for prediabetes. Because this group includes a broader range of persons at risk for 
diabetes, the default annual probability of diabetes is slightly lower at 3.6%. 
2.4.3 Persons with High-Risk Prediabetes 
This group is a subset of the group with prediabetes. This group is the smallest (about 34% 
of the prediabetes group), but it represents those with the highest risk of progressing to 
diabetes. “Persons with high-risk prediabetes” are defined as persons with an A1C between 
6.0% and 6.4% (Selvin et al., 2010) or an FPG between 110 and 125 mg/dl (Nichols et al., 
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2010). This risk group has the highest annual probability of diabetes, with a default value of 
6.2%. See Section 2.4 of the Technical Report for more information on how thresholds and 
annual probabilities were determined for each risk group. 
2.5 Additional Impact Toolkit Inputs 
After selecting your population characteristics and risk group, you can customize additional 
inputs by clicking on the “CUSTOMIZE FURTHER” button (Figure 5). For these additional 
inputs, we recommend beginning with “Screening” in the left column and ending with 
“Medical Costs” in the right column (your choice of screening options will affect subsequent 
input choice). In other words, read through and customize the inputs as if you were reading 
a newspaper. First go down the left column, and then go down the right column (note: 
depending on the browser window or device you are using to view the Impact Toolkit, input 
fields may appear in a different number of columns). 
Figure 5. Accessing Additional Modifiable Inputs Using the “CUSTOMIZE 
FURTHER” Button 
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Although everyone in your population can be recruited and screened for the National DPP, 
only a minority of this target population will actually be eligible and willing to participate in 
the program. If they do participate, they are assumed to benefit from weight loss, diabetes 
risk reduction, and medical cost reduction associated with this prevention program. In 
Sections 2.5.1 through 2.5.7, we describe all assumptions related to providing the National 
DPP in your population. In Section 3, we describe how to interpret the costs and benefits 
realized by offering this program, as reported in the Output Dashboard. 
2.5.1 Screening 
In the Screening section, you can choose if you would like to screen potential participants 
for prediabetes, if they have not already been screened (Figure 6). The default setting for 
the Impact Toolkit assumes that 46% of your population has undergone screening recently 
(see Section 2.5.2) and knows their prediabetes status (although this assumption can be 
altered in the “Program Enrollment and Participation” [see Section 2.5.2]). If you choose to 
conduct screening for unscreened persons in your population, then screening costs will be 
incurred (also discussed further in Section 2.5.5). 
Figure 6. Screening Inputs in the Impact Toolkit 
 
 
Screening costs are shown in the screening cost calculation box in the Program Costs 
section (the box will appear in that section if you have chosen to conduct a screening 
program). This box calculates the average screening cost per person as the product of the 
assumed screening cost ($12.50 in the default setting) and the average number of people 
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screened per case detected (two in the default setting). This calculation allows us to account 
for the costs of negative screenings in the overall program costs. For further details on 
program cost calculations, see Section 2.5.5 on program costs. To assume a different 
number of people screened for the average screening cost calculation, edit the number in 
the box for “Average number of people screened for each case of prediabetes detected.” An 
increase in this number would reflect an unscreened population with a lower prevalence of 
prediabetes, whereas a decrease would reflect an unscreened population with a higher 
prevalence of diabetes. If you are not sure about the underlying prevalence in your 
unscreened population, then we recommend using the default setting of two people 
screened per case detected. This reflects a prevalence of prediabetes of about 50% among 
unscreened people that agree to participate in a screening program. To our knowledge, 
there are no extant data on the prevalence of prediabetes among people who participate in 
a screening program. Although the typical prevalence of prediabetes is lower than 50%, we 
assumed that it would be higher among a self-selected group of screening participants (i.e., 
people are more likely to agree to screening if they have risk factors for prediabetes).   
2.5.2 Program Enrollment and Participation 
In this section, you can enter the percentage of eligible participants that have already been 
screened for prediabetes (Figure 7). The default setting is 46%, which is based on the 
percentage of people at risk for diabetes who have been screened in the past 3 years 
(Bullard et al., 2015; Kiefer et al., 2015). People at risk for diabetes include adults aged 45 
or older or those with physical inactivity, family histories of diabetes, high blood pressure, 
and other risk factors per the ADA (ADA, 2016) and U.S. Preventive Services Task Force 
(Calonge et al., 2008) criteria for screening for type 2 diabetes. Other analyses have shown 
that only about 11% of persons with prediabetes in 2010 were both screened and aware of 
their disease status (CDC, 2013). This 11% value can be entered as an alternative to the 
default value of 46%. 
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Figure 7. Program Enrollment and Participation Inputs in the Impact Toolkit 
 
 
If you have chosen to conduct additional screening for your program, then you can also 
input the “percentage of eligible, previously unscreened persons receiving screening” (the 
entry field for this input will only be shown if you have chosen to conduct screening in the 
screening section). The default value is 100%, which assumes that all persons with a  
BMI ≥24 who have not been screened will receive screening. You can adjust this value 
downward as appropriate for your population. 
Next, you enter your assumed participation rate. The default setting for the participation 
rate is 35%, which is based on the participation rate in a demonstration of the National DPP 
with large employers (R. Li, R. Ackermann, personal communication, June 22, 2015). The 
participation rate might be higher or lower for your population based on the incentives 
offered for participating or the perceived benefits of participation.  
In the final field shown in this section, the program enrollment and participation inputs are 
used to determine the total percentage of participation among eligible adults. The Impact 
Toolkit calculates this value automatically. For example, if 46% of eligible adults have 
previously been screened, no additional screening occurs (the default value), and the 
participation rate is 35%, then the total percentage of eligible adults participating will be 
16% (46% x 35%=16%). This percentage is then applied to the predicted prevalence of the 
selected risk group to get the percentage of projected participants. For example, in the 
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default setting, the predicted prevalence of “persons with prediabetes” is 29% in the 
national sample. Thus, 29% x 16% = 4.7% of the total population that will participate in 
the National DPP if no additional screenings are conducted. However, in a scenario where a 
screening program is conducted to identify additional eligible persons, the calculation is 
somewhat more complex (see Equation 1). 
Equation 1. Percentage of Screened Population Who Participate in the Intervention 
Percentage of screened 
population who participate 
in the intervention 
= % of population previously screened for prediabetes x % 
of screened persons participating in intervention + 
[(100% − % of population previously screened for 
prediabetes) x % of previously unscreened persons 
receiving screening x % of screened persons 
participating in intervention] 
 
Similar to the example with no additional screenings, the percentage from Equation 1 
(which is used when there are additional screenings) is applied to the predicted prevalence 
of the selected risk group (e.g., 29% for “persons with prediabetes” in the national sample) 
to get the percentage of projected participants. For example, if the “% of previously 
unscreened persons receiving screening” is 100%, then we would calculate the percentage 
of projected participants as 29% x (46% x 35%) + [(100% − 46%) x100% x 35%], which 
equals 16% of the total population that will participate in the National DPP if additional 
screenings are conducted on 100% of the previously unscreened population. 
2.5.3 Intervention Weight Loss and Regain Schedule 
The DPP trial demonstrated that participants in an intensive lifestyle intervention lost about 
7.2% of their weight in the first year of the program (Hamman et al., 2006; Knowler et al., 
2002). Real-world adaptations of the DPP trial, such as the National DPP, resulted in a 
smaller weight loss, 4.4% on average at the end of the first year of follow-up (R. Li, 
personal communication, June 24, 2015). This estimate is based on results from the 
National DPP and represents the first year weight loss for program participants and is 
supported by other studies.3 A participant was defined as someone attending at least 4 of 
the 16 program sessions. Attending at least 9 sessions was associated with a slightly higher 
weight loss (5.1%) (R. Li, personal communication, June 24, 2015). 
The DPP trial and studies of real-world interventions with additional years of follow-up show 
that the initial weight lost is regained in future years. Based on data from these studies, we 
assume that about 50% of the weight lost is regained in Year 2, and another 20% is 
regained in Year 3 (Barte et al., 2010) (Figure 8). In Years 4 through 10, we assume that all 
                                          
3 In 2012, Ali et al. (2012) reported a 4.1% weight loss at 12-month follow-up for translational 
programs conducted in the United States and modeled on the Diabetes Prevention Program (DPP) 
trial’s lifestyle intervention. 
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the weight lost has been regained (0% weight loss relative to baseline weight). These 
weight loss and regain assumptions are based on group-based National DPPs or similar 
programs with a minimum of 16 sessions over the first 6 months. A minimum of 6 sessions 
must be offered in the second 6 months of the program to achieve full recognition status 
per the criteria set forth by CDC (CDC, 2015b). Although these default settings are based 
on the best available data for the average National DPP participant, your population and 
program may differ from the average. You can modify these weight loss and regain 
assumptions according to the expectations for your program. We limit weight loss to a 
maximum of 10%; weight loss higher than 10% would lead to results with low credibility 
under the current model assumptions.   
Figure 8. Intervention Weight Loss and Regain Inputs in the Impact Toolkit 
 
 
2.5.4 Program Budget 
In the default setting, the Impact Toolkit assumes that a state, employer, or insurer will 
offer the program to all eligible persons who want to participate. However, if the budget is 
limited for implementing a National DPP or similar program, then you can check the box in 
this section to set a maximum budget. Once you have checked this box, an additional entry 
field will appear for you to enter your maximum budget (Figure 9). This budget you enter 
will limit the number of program participants based on the size of your eligible population, 
your program costs, and your screening costs (if you choose to screen previously 
unscreened persons). 
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Figure 9. Program Budget Input in the Impact Toolkit 
 
 
2.5.5 Program Costs 
Here you can enter the per person costs of your program. The default cost of $417 (2013 
U.S. dollars) is the per-participant cost of a group-based National DPP or similar program 
without screening costs included (Li et al., 2015). All costs in this section should be 
calculated and entered per participant. If you are conducting a screening program (i.e., 
selected “Screen persons for prediabetes if they have not been previously screened” in the 
screening section), then this section will also show an “Average Screening Cost Calculation” 
box. Here, we assume that screening costs are $12.50 in the default setting. Either the FPG 
test ($7.22) or the hemoglobin A1c test ($17.85) can be used to diagnose prediabetes, so 
we assume the average cost ($12.50) of these two tests according to the 2015 Medicare 
Laboratory Fee Schedule (CMS, 2016a) (Figure 10). 
If you do not plan to use one of these tests or believe that your screening costs differ from 
these estimates, then the screening test costs can be modified in this section. If you plan to 
use the CDC Prediabetes Screening Test (CDC, 2015) (a questionnaire that can also be used 
to determine eligibility for the National DPP) to identify potential participants, then your 
costs may be lower than either of the blood test costs (e.g., the cost of printing and 
distributing self-administered questionnaires). We also assume that there are “Other 
screening costs,” which include the cost of a brief follow-up visit to discuss the patient’s 
screening test results and receive a referral to a program such as the National DPP. The 
default cost of $20 for “Other screening costs” only includes the cost of a brief office visit 
and not the costs of recruitment for screening. “Other screening costs” are based on the 
2015 Medicare Physician Fee Schedule (CMS, 2016b) associated with an evaluation and 
management visit of low complexity (HCPCS Code 99211) for an established patient (about 
5 minutes of face-to-face time at the cost of $20.02). The average total screening costs per 
participant are shown in the “Average Screening Cost Calculation” section shown in Figure 
10. In the default scenario, the average screening costs total $65 per participant. This total 
accounts for the screening test cost (lab costs of $12.50 in the default), other screening 
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costs (physician time of $20 in default), and the cost of negative screenings (number 
screened per case detected equals 2 in the default). For more information on these 
assumptions and how the screening costs are calculated, see Section 2.5.5 of the Technical 
Report. This cost can be adjusted to reflect a more intensive screening program with 
recruitment costs. All screening costs are included in the overall program costs that are 
used to calculate net costs and other results in the Output Dashboard. 
Figure 10. Program Cost Inputs in the Impact Toolkit 
 
 
2.5.6 Medical Costs 
In the year that a person is diagnosed with diabetes, he or she will have substantial medical 
costs associated with diagnosing and treating their diabetes. In each subsequent year, the 
person will continue to have medical costs for the treatment of his or her disease, although 
not as great as the initial year of diagnosis. These are sometimes called diabetes-
attributable medical costs, and they are defined as the excess medical costs for a person 
with diabetes compared with a similar person without diabetes. 
User Manual for the Diabetes Prevention Impact Toolkit 
2-18 
The default values that are provided in the Impact Toolkit reflect the average excess 
medical costs for persons with diabetes based on a CDC analysis of longitudinal medical 
claims data from MarketScan (2001–2013) (Shrestha et al., 2016). Based on these data 
and a review of other cost analyses, we assumed default values of $6,424 for the first year 
of diagnosis and $3,900 for the years after diagnosis (2013 U.S. dollars) (Figure 11). First 
year costs are approximately 1.65 times greater than subsequent year costs. If you believe 
that excess medical costs associated with diabetes differ in your population, we suggest 
maintaining this approximate relationship between the first year costs and the subsequent 
year costs. We also suggest staying within the suggested range of $3,300 to $9,900 for first 
year costs and $2,000 to $6,000 for subsequent year costs. Using excess medical cost 
estimates outside of these ranges may lead to results with low credibility in the 10-year 
outcomes projected by the Impact Toolkit. Diabetes-attributable costs in the Impact Toolkit 
are associated with the first 10 years of costs for a newly diagnosed case of diabetes 
(Srestha et al., 2016). Medical costs after the first 10 years may be higher.   
Figure 11. Medical Cost Inputs in the Impact Toolkit 
 
 
In the Impact Toolkit, all costs incurred in the future are discounted back to the present 
using a discount rate assumed in the Medical Cost section of the Input Dashboard. The 
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discount rate input box allows us to account for the fact that the money we have today has 
more value than money received in the future. This accounts for future inflation, lost 
investment opportunity, and risk. Applying this discount value allows us to more accurately 
compare the money that will be spent in the future with the money that is spent today. An 
annual discount rate of 1.0% to 5.0% is commonly used. Our default value is 3.0%.  
2.5.7 Productivity Costs (Employer Module Only) 
In the Employer module only, we include productivity costs associated with diabetes. We 
limit productivity costs to the costs of days of work missed due to diabetes and the value of 
these days. The value of the days of work missed (per person) is calculated by multiplying 
the “Days of work missed per year due to diabetes” and the “Daily earnings for persons with 
diabetes.” Days of work missed per year due to diabetes are the excess days of work 
missed by someone with diabetes compared with a similar person without diabetes (e.g., 
similar age, sex, comorbidities). 
We found that, on average, a person with diabetes will miss 3.3 more days of work each 
year compared with a similar person without diabetes. The default daily earnings of $276 
was calculated based on wage data from the 2014 Current Population Survey (CPS) 
(Figure 12). See Section 2.5.7 of the Technical Report for more detail on how default 
estimates were obtained. 
Figure 12. Productivity Cost Inputs in the Impact Toolkit (Employer Module 
Only) 
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After filling in all the fields discussed in Sections 2.1 through 2.5, click “GET RESULTS” to 
view your customized results in the Output Dashboard. See Section 3 for information about 
calculations made in the Output Dashboard and how to interpret results. 
 3-1 
3. OUTPUT DASHBOARD 
The results in the Output Dashboard are unique to your data inputs. They predict the health 
and economic outcomes for your program participants as a result of implementing the 
National DPP or a similar program. The results include a set of seven figures and two tables. 
Each figure has an associated data table that can be viewed by clicking on the “SHOW DATA 
TABLE” bar below each figure. The data tables include all the data shown in the figure and, 
in some cases, show additional data not directly used in the figure. The data tables also 
contain footnotes for some of the data elements that may be helpful. In general, reading 
the tooltips (green circle with an “i”) next to each figure title will provide you with the most 
relevant information for reading and interpreting the figure. This User Manual and the 
Technical Report provide further detail as well. To focus on just a few key figures, use the 
“X” in the upper right-hand corner of each figure to temporarily hide that figure. To restore 
all the figures, just click “RESTORE RESULTS” in the upper right-hand corner of the Output 
Dashboard. 
3.1 Projected Participants 
Figure 13 shows how the projected number of participants is calculated from the total 
population. The total adult population being considered for the National DPP is shown in the 
top bar in the figure. This is determined by the total adult population in your state (State 
module), the number of employees at your company (Employer module), or the number of 
insured adults (Insurer module). In the second bar from the top, a subset of the total 
population is projected to be eligible for the intervention based on (1) the assumed 
population characteristics (Sections 2.1 through 2.3) and (2) the risk group selected in the 
Input Dashboard (Section 2.4). Next, some or all (depending on your screening inputs, see 
Sections 2.5.1 and 2.5.2) of the eligible persons have been previously or newly screened, 
confirming their eligibility for the intervention (shown in the third bar from the top). Among 
the eligible, screened persons, some or all (depending on your participation inputs, see 
Section 2.5.2) will participate in the intervention. The predicted number of participants is 
shown in the bottom bar of this figure. This number is calculated by the Impact Toolkit. 
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Figure 13. Projected Number of Participants 
 
 
3.2 Cumulative Projected Cases of Diabetes and Cumulative Years 
with Diabetes Averted  
The chart on the left of Figure 14 shows the effect of the National DPP or similar programs 
on new cases of diabetes. Specifically, it shows the cumulative number of diabetes cases 
with and without the National DPP intervention for your population of participants (the 
projected number of participants is reported in the heading for the chart). The gray line 
estimates the number of new diabetes cases without the National DPP. The green line 
represents the number of new diabetes cases with the National DPP. The difference between 
the two lines represents the cases of diabetes averted at a given point in time. The 
maximum number of “Cases Averted” in a single year will usually occur in the last year 
assumed to have some weight loss effect (Year 3 in the default setting). In the chart on the 
right in Figure 14, the cumulative years with diabetes averted is shown for your population 
of participants (the projected number of participants is also reported in the heading for this 
chart). The cumulative years with diabetes averted (by the National DPP or similar 
programs) is the cumulative calculation of the cases averted in each year. Clicking on the 
“SHOW DATA TABLE” button will open up a table with more information. The table shows 
the number of “Cases Averted” in each year as well as the “Years of Diabetes Averted.” 
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Figure 14. Cumulative Projected Cases of Diabetes 
 
 
3.3 Cumulative Medical Costs per Participant 
Figure 15 shows the difference in cumulative medical costs with and without the National 
DPP intervention. Results are displayed per participant and can be easily scaled up by 
multiplying results by your number of participants. The gray bar on the left indicates the 
cumulative medical costs without the National DPP, and the green bar on the right indicates 
the cumulative medical costs with participation in the National DPP. The cumulative medical 
cost savings is the difference between these amounts. Click on the “SHOW DATA TABLE” 
button to see more detailed information. 
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Figure 15. Cumulative Medical Costs per Participant 
 
 
Results in this figure are largely affected by the medical cost assumptions (Section 2.5.6), 
the assumed annual probability of developing diabetes for your risk group, and the assumed 
weight loss effects. Even when the excess medical costs of diabetes are assumed to be large 
(e.g., $6,425 in the year of diagnosis and $3,900 in subsequent years in the default 
setting), the average difference in medical costs can be fairly small. This is due to the fact 
that (1) only a fraction of participants develop diabetes each year (e.g., 3.8% each year in 
the default setting for persons with prediabetes), and (2) only a fraction of the projected 
cases of diabetes are averted among participants (this will depend on the weight loss/regain 
assumptions). 
3.4 Net Costs (Program Costs minus Medical Cost Savings) per 
Participant 
Figure 16 uses the cumulative medical costs (Section 3.3) and the cumulative program 
costs (Section 2.5.2) to generate the cumulative net cost per participant. In the Employer 
module, productivity costs are also included. In each year, the cumulative medical cost 
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savings (and productivity cost-savings in the Employer module) are subtracted from the 
cumulative program cost to produce the cumulative net cost in that year. Results are 
displayed per participant and can be easily scaled up by multiplying results by your number 
of participants. 
In general, the cumulative net costs decrease over time, so that by Year 10 or sooner, there 
may be negative cumulative net costs, indicating that the program is cost-saving. Net costs 
fall because the program cost is only paid once, in Year 1, whereas medical cost savings as 
a result of program participation occur each year. The net cost calculation is most sensitive 
to your assumptions regarding the program cost, the weight loss/regain, and the medical 
costs. Click on the “SHOW DATA TABLE” button to see more information. It should be noted 
that net costs only include medical and program costs and do not otherwise reflect the 
health benefits to participants.  
Figure 16. Net Costs (Program Costs minus Medical and Productivity Cost 
Savings) per Participant 
  
 
3.4.1 Productivity Costs in the Employer Module 
In the Employer module, productivity cost-savings are calculated in addition to medical 
cost-savings. In the net costs figure (see Figure 16), these productivity cost-savings are 
also subtracted from the overall program costs in each period to get the net costs. For each 
new case of diabetes, a number of days of work are missed each year due to diabetes (3.3 
days in the default setting; see Section 2.5.6). Each day is valued by the average wages 
assumed for your employee population ($276 per day in the default setting). For example, 
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in the default setting, about $911 in productivity costs are incurred each year for everyone 
that has developed diabetes in that cycle or a previous cycle. Click on the “SHOW DATA 
TABLE” button to see the detailed 10 year data in the Impact Toolkit. 
3.5 Cumulative Quality Adjusted Life Years (QALYs) Gained 
Figure 17 shows the cumulative quality-adjusted life years (QALYs) gained for your 
population of participants (the projected number of participants is reported in the heading). 
QALYs are a combined measure of health and time, allowing us to weight years lived by the 
health-related quality of life in those years. One QALY is equal to 1 year of life with a perfect 
quality of life. 
When a person develops diabetes, we assume that their quality of life is reduced by about 
5%, on average. The estimate of a 5% reduction in quality of life is based on the quality of 
life decrement associated with progressing from prediabetes to diabetes in the CDC/RTI 
model of diabetes.4 This reduction in quality of life is averted or delayed with each case of 
diabetes that is averted or delayed (due to the National DPP or similar programs). The 
cumulative QALYs gained (shown in Figure 17) account for averting the reduction in quality 
of life associated with diabetes as well as the timing of when cases are averted. For 
instance, if weight losses are maintained throughout the whole 10-year period, then cases 
of diabetes will be delayed for a longer amount of time and QALY gains will be greater. If 
weight losses are quickly regained, then these cases of diabetes are not delayed as long and 
not as many QALYs will be gained. 
                                          
4 A quality of life decrement of 0.04 relative to a baseline utility of 0.84 for persons without diabetes 
represents about a 5% decrease in quality of life. 
Section 3 — Output Dashboard 
3-7 
Figure 17. Cumulative Quality Adjusted Life Years (QALYs) Gained 
  
 
3.6 Incremental Cost-Effectiveness Ratio (ICER) 
Figure 18 shows the annual net costs per participant, QALYs gained per participant, the 
Incremental Cost-Effectiveness Ratio (ICER) (net costs divided by QALYs gained), and the 
Cost per Case Averted (cumulative cases averted or “Years of Diabetes Averted” divided by 
the Net Costs). The ICER is a measure of the cost-effectiveness or “return on investment” 
associated with an intervention. It is calculated as the cumulative net costs divided by the 
cumulative QALYs gained. A lower ICER is better as it indicates that QALYs are gained from 
the intervention at a lower cost. A negative ICER indicates that the intervention is 
associated with QALY gains and reduced costs (i.e., a cost-saving intervention). Negative 
ICERs are shown in Figure 18 as “Cost-saving.” 
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The Cost per Case Averted is found by dividing the cumulative cases averted (as seen in 
“Cumulative Projected Cases of Diabetes” figure) by the cumulative net cost. A negative 
cost per case averted means that the program is cost saving by that point in time. Negative 
costs per case averted are shown in Figure 18 as “Cost-saving.” 
Figure 18. Incremental Cost-Effectiveness Ratio (ICER) 
 
 
3.7 Cumulative Years of Life Gained 
Developing diabetes is associated with an increased risk of life-threatening events, such as 
heart attack and stroke. We assumed that persons with diabetes have twice the risk of 
dying in a given year compared with persons without diabetes, on average (Geiss et al., 
1995). When cases of diabetes are averted or delayed (due to the intervention), a small 
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decrease in the number of diabetes-related deaths is achieved. These deaths averted are 
associated with a gain in the years of life lived during the 10-year period. 
Figure 19 shows the cumulative years of life gained for your participant population as a 
result of participation in the National DPP (the projected number of participants is reported 
in the heading). These years of life gained do not account for the quality of life with diabetes 
as in the QALYs gained figure. Click on the “SHOW DATA TABLE” button to see more 
information. Results are calculated dynamically in the Output Dashboard and are often 
rounded to accommodate the best display of the results given the space restrictions. To 
view the unrounded results, download your results in Microsoft Excel using the green button 
in the upper right-hand corner of the Output Dashboard (see Section 4.2). 
Figure 19. Cumulative Years of Life Gained 
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4. EXPORTING RESULTS FROM THE IMPACT TOOLKIT 
4.1 Printing Results to a PDF 
To print results to a PDF, click the green “PDF” icon at the top of the Output Dashboard. 
This will generate a report of your customized results, including all figures (even figures that 
may have been discarded using the “X” in the upper right-hand corner of each output 
figure). The report will be downloaded to your computer. Open the report and print it or 
save it to the appropriate location on your computer.  
4.2 Exporting Results to Excel 
To generate an Excel workbook with your results data, click the green “XLSX” icon at the 
top of the Output Dashboard. The report will be downloaded to your computer. Open the 
report and save it to the appropriate location on your computer. 
The first tab in the workbook is “User Inputs.” This tab displays all default input values, as 
well as the values used in your analysis. The subsequent tabs each correspond to the output 
figures described in Sections 3.1 through 3.7. These tabs contain the data used to create 
the graphs, but they do not include the figures. This format allows you to create customized 
graphs and perform additional analyses. Also, downloading your results in Excel allows you 
to see all results without rounding. Because results are calculated dynamically in the Output 
Dashboard, they are sometimes rounded to accommodate the best display of the results 
given the space restrictions.  
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5. COMPARING SCENARIOS IN THE IMPACT TOOLKIT 
The Impact Toolkit has the ability to calculate health and economic projections for any 
combination of the more than 20 user-modifiable inputs. If you are projecting the health 
and economic impacts of a National DPP for your state, employee, or insured population, 
then you may be interested in testing the sensitivity of these impacts to changing inputs, 
such as program costs. Other key inputs that may differ in your population and program 
include the weight loss and regain schedule, the use of a screening program, and the 
percentage of eligible, screened persons that participate. 
There are several ways to compare scenarios in the Impact Toolkit. Choose the method that 
best fits your needs: 
1. Use the panel of Selected Inputs to modify input values while viewing results in the 
Output Dashboard. 
a. In this method, the panel of Selected Inputs is populated with your current input 
values. By changing them and clicking “MODIFY,” you can instantly view the 
recalculated results in the Output Dashboard. This approach is suitable for 
comparing individual outcomes, such as the net cost in Year 3; however, if you 
are comparing multiple outcomes, it is difficult to recall more than one number 
from the previous results. 
2. Output your initial results to a pdf or Excel workbook. Modify inputs using the panel 
or the full Input Dashboard, get new results, and output the new results to a pdf or 
Excel workbook for comparison. 
a. This method for comparing scenarios is more time-consuming; however, it allows 
for a more detailed comparison of results across all the outcomes projected by 
the Impact Toolkit. Generating a pdf will provide you with a report containing all 
the figures and tables generated in the Output Dashboard. In contrast, the Excel 
workbook only contains the tables from the Output Dashboard. If you are 
proficient with Excel, then more sophisticated comparisons and figures can be 
generated using Output from multiple scenarios. 
3. Open two browser windows or tabs, and generate two sets of results to view. 
a. This method is convenient and allows you to compare multiple results 
simultaneously by switching between windows or tabs. The Input Dashboard will 
only remember one set of inputs (the last set of inputs used) if you return to it to 
generate another scenario. Note: Different browsers may have different settings 
for saving previously entered data, such as Input values in the Impact Toolkit. 
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